N-[3-(methylamino)propyl]oxolane-2-carboxamide

Names

[ CAS No. ]:
81403-67-0

[ Name ]:
N-[3-(methylamino)propyl]oxolane-2-carboxamide

[Synonym ]:
2-Furancarboxamide, tetrahydro-N-[3-(methylamino)propyl]-
Tetrahydrofuran-2-carboxylic acid (3-methylaminopropyl)amide
N-[3-(Methylamino)propyl]tetrahydro-2-furancarboxamide
N-<3-(methylamino)propyl>tetrahydrofuran-2-carboxamide
tetrahydro-N-<3-(methylamino)propyl>-furancarboxamide
N1-methyl-N2-tetrahydrofuroylpropylenediamine
N-[3-(methylamino)propyl]-2-oxolanecarboxamide
tetrahydro-N-[3-(methylamino)propyl]-2-furancarboxamide
N1-Methyl-N2-(tetrahyrofuroyl-2-)-propylene diamine

Chemical & Physical Properties

[ Density]:
1.0±0.1 g/cm3

[ Boiling Point ]:
380.8±42.0 °C at 760 mmHg

[ Molecular Formula ]:
C9H18N2O2

[ Molecular Weight ]:
186.251

[ Flash Point ]:
184.1±27.9 °C

[ Exact Mass ]:
186.136826

[ PSA ]:
50.36000

[ LogP ]:
-1.49

[ Vapour Pressure ]:
0.0±0.9 mmHg at 25°C

[ Index of Refraction ]:
1.477

Safety Information

[ HS Code ]:
2932190090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • PHYTASE
  • Methyl tetrahydro-2-furoate
  • N-METHYL-1,3-PROPANEDIAMINE
  • 2-Tetrahydrofuroic acid

DownStream

  • Alfuzosin hydrochloride
  • Alfuzosin

Customs

[ HS Code ]: 2932190090

[ Summary ]:
2932190090 other compounds containing an unfused furan ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

Related Compounds

  • N-[3-(methylamino)propyl]-N-(2,4,6-trimethylphenyl)formamide
  • N-[3-[(2-hydroxyphenyl)methylamino]propyl]-2,2,5,5-tetramethyl-1H-pyrrole-3-carboxamide
  • N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]furan-2-carboxamide
  • N-(3-carbamoyl-4,5-dimethylthiophen-2-yl)oxolane-2-carboxamide
  • N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
  • tert-Butyl 3-(methylamino)propylcarbamate
  • N-[2-[5-(Furan-2-yl)thiophen-2-yl]-2-hydroxyethyl]cyclobutanecarboxamide
  • 3-(2-Oxo-2-{3-[(pyrimidin-2-yloxy)methyl]piperidin-1-yl}ethyl)-3,4-dihydroquinazolin-4-one
  • N-(1-{3-cyclopropyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}azetidin-3-yl)-3-methoxy-N-methylbenzamide
  • Ethyl 5-(1H-pyrrol-2-yl)-1,2,4-oxadiazole-3-carboxylate
  • 2-(4-{3-Methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}-1,4-diazepane-1-carbonyl)indolizine
  • N-{[4-(furan-2-yl)thiophen-2-yl]methyl}cyclopropanecarboxamide
  • 2-{[1-(2-phenyl-1,3-thiazole-4-carbonyl)piperidin-4-yl]methyl}-2H,3H,5H,6H,7H-cyclopenta[c]pyridazin-3-one
  • (4-Morpholin-4-ylphenyl)-[4-([1,2,4]triazolo[4,3-b]pyridazin-6-yl)-1,4-diazepan-1-yl]methanone
  • 1-Ethyl-7-methyl-4-oxo-N-prop-2-ynyl-1,8-naphthyridine-3-carboxamide
  • 3-[(oxolan-3-yl)methoxy]-N-(thiophen-2-yl)azetidine-1-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.